US › Healthcare

Elutia Inc. (ELUT)

US · Healthcare · Medical Devices

$0.85+4.94%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$2.4M

Revenue YoY

-61.2%

Net profit

$-7.6M

EPS

$-0.17

EPS estimate

$-0.15

Net margin

-315.0%

EPS came in at -0.17 against a street estimate of -0.15 — a miss of 13.3%.

Key statistics

Market cap

$35.9M

Forward P/E

0.0

P/B

2.28

Book value

$0.36

EPS (TTM)

$-0.63

52-week high

$1.39

52-week low

$0.50

50-day MA

$0.90

200-day MA

$0.94

Beta

0.88

Analyst view

Analysts rate Elutia Inc. a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $5.00.

Shareholding

Insiders

3.50%

Institutions

43.82%

Largest institutional holders

Fund	Stake
Nantahala Capital Management, LLC	7.19%
AIGH Capital Management, LLC	6.09%
Knollwood Investment Advisory LLC	5.77%
SILVERARC CAPITAL MANAGEMENT, LLC	5.64%
Vanguard Capital Management, LLC	2.31%
Perkins Capital Management Inc	1.71%
Geode Capital Management, LLC	0.66%
CI Private Wealth LLC	0.57%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Elutia Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.